Messing A - Search Results

1

Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies.

Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E, Land W, Ollivierre H, Jortner B, Switzer R 3rd, Messing A, Rouault TA. Smith SR, et al. Among authors: messing a. Ann N Y Acad Sci. 2004 Mar;1012:65-83. doi: 10.1196/annals.1306.006. Ann N Y Acad Sci. 2004. PMID: 15105256

2

Somatostatin as a trophic factor. Analysis of transgenic mice overexpressing somatostatin in astrocytes.

Schwartz JP, Taniwaki T, Messing A, Brenner M. Schwartz JP, et al. Among authors: messing a. Ann N Y Acad Sci. 1996 Mar 22;780:29-35. doi: 10.1111/j.1749-6632.1996.tb15109.x. Ann N Y Acad Sci. 1996. PMID: 8602737 No abstract available.

3

P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells.

Feltri ML, D'Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L. Feltri ML, et al. Among authors: messing a. Ann N Y Acad Sci. 1999 Sep 14;883:116-23. Ann N Y Acad Sci. 1999. PMID: 10586237

4

Peripheral nerve dysmyelination due to P0 glycoprotein overexpression is dose-dependent.

Quattrini A, Feltri ML, Previtali S, Fasolini M, Messing A, Wrabetz L. Quattrini A, et al. Among authors: messing a. Ann N Y Acad Sci. 1999 Sep 14;883:294-301. Ann N Y Acad Sci. 1999. PMID: 10586254

5

GFAP Transgenic Mice.

Brenner M, Messing A. Brenner M, et al. Among authors: messing a. Methods. 1996 Dec;10(3):351-64. doi: 10.1006/meth.1996.0113. Methods. 1996. PMID: 8954847

6

Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease.

Abel A, Bone LJ, Messing A, Scherer SS, Fischbeck KH. Abel A, et al. Among authors: messing a. J Neuropathol Exp Neurol. 1999 Jul;58(7):702-10. doi: 10.1097/00005072-199907000-00004. J Neuropathol Exp Neurol. 1999. PMID: 10411340

7

Peripheral Nerve Dysmyelination Due to P₀ Glycoprotein Overexpression Is Dose-Dependent.

Quattrini A, Feltri ML, Previtali S, Fasolini M, Messing A, Wrabetz L. Quattrini A, et al. Among authors: messing a. Ann N Y Acad Sci. 1999 Oct;883(1):294-301. doi: 10.1111/j.1749-6632.1999.tb08591.x. Ann N Y Acad Sci. 1999. PMID: 29086950

8

P₀-Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells.

Feltri ML, D'Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L. Feltri ML, et al. Among authors: messing a. Ann N Y Acad Sci. 1999 Oct;883(1):116-123. doi: 10.1111/j.1749-6632.1999.tb08574.x. Ann N Y Acad Sci. 1999. PMID: 29086916

9

Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.

Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ. Scherer SS, et al. Among authors: messing a. J Neurosci. 2005 Feb 9;25(6):1550-9. doi: 10.1523/JNEUROSCI.3082-04.2005. J Neurosci. 2005. PMID: 15703409 Free PMC article.

10

GFAP promoter directs astrocyte-specific expression in transgenic mice.

Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A. Brenner M, et al. Among authors: messing a. J Neurosci. 1994 Mar;14(3 Pt 1):1030-7. doi: 10.1523/JNEUROSCI.14-03-01030.1994. J Neurosci. 1994. PMID: 8120611 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters